BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10576776)

  • 21. Synthesis and in vitro calcium antagonist activity of 4-aryl-7,7-dimethyl/1,7,7-trimethyl-1,2,3,4,5,6,7,8-octahydroquinazoline-2,5-dione derivatives.
    Yarim M; Saraç S; Kiliç FS; Erol K
    Farmaco; 2003 Jan; 58(1):17-24. PubMed ID: 12595033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and conformation analysis of 3-substituted derivatives of 1H,3H-pyrido[2,3-d] pyrimidin-4-one of expected depressive nervous system. Part III.
    Chodkowski A; Herold F; Kleps J
    Acta Pol Pharm; 2004; 61(1):45-54. PubMed ID: 15259857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and calcium modulatory activity of 3-alkyloxy-carbonyl-4-(disubstituted)aryl-5-oxo-1,4,5,6,7,8-hexa-hydroquinoline derivatives.
    Simşek R; Oztürk GS; Vural IM; Gündüz MG; Sarioglu Y; Safak C
    Arch Pharm (Weinheim); 2008 Jan; 341(1):55-60. PubMed ID: 17994603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and biological investigations of some 5H-1,3,4-oxadiazolo[3,2-a]pyrimidin-5-ones.
    Soliman FS; Shafik RM; Darwish M
    J Pharm Sci; 1982 Feb; 71(2):178-82. PubMed ID: 7062240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New thiazolo[3,2-a] pyrimidine derivatives, synthesis and calcium antagonistic activities.
    Balkan A; Tozkoparan B; Ertan M; Sara Y; Ertekin N
    Boll Chim Farm; 1996 Dec; 135(11):648-52. PubMed ID: 9138461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and calcium antagonistic activity of some new 2-thioxo-1,2,3,4-tetrahydropyrimidine derivatives.
    Ertan M; Balkan A; Saraç S; Uma S; Renaud JF; Rollad Y
    Arch Pharm (Weinheim); 1991 Mar; 324(3):135-9. PubMed ID: 1830467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. One-pot three-component Biginelli-type reaction to synthesize 3,4-dihydropyrimidine-2-(1H)-ones catalyzed by Co phthalocyanines: Synthesis, characterization, aggregation behavior and antibacterial activity.
    Medyouni R; Elgabsi W; Naouali O; Romerosa A; Sulaiman Al-Ayed A; Baklouti L; Hamdi N
    Spectrochim Acta A Mol Biomol Spectrosc; 2016 Oct; 167():165-174. PubMed ID: 27287623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3-Acetyl-4-aryl-5-oxo-2,7,7-trimethyl-1,4,5,6,7,8-hexahydro-quinoline derivatives and their calcium antagonistic activities.
    Safak C; Ozkanli F; Erol K; Aktan Y
    Arzneimittelforschung; 1995 Nov; 45(11):1154-6. PubMed ID: 8929229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and biological activity of two new calcium-channel blockers, mebudipine and dibudipine.
    Mahmoudian M; Mirkhani H; Nehardani Z; Ghiaee S
    J Pharm Pharmacol; 1997 Dec; 49(12):1229-33. PubMed ID: 9466348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N1-Alkylated 3,4-dihydropyrimidine-2(1H)-ones: Convenient one-pot selective synthesis and evaluation of their calcium channel blocking activity.
    Singh K; Arora D; Poremsky E; Lowery J; Moreland RS
    Eur J Med Chem; 2009 May; 44(5):1997-2001. PubMed ID: 19008020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and pharmacological investigation of some novel 2-phenyl-3-(substituted methyl amino) quinazolin-4(3H)-ones as H1-receptor blockers.
    Alagarsamy V; Venkatesaperumal R; Vijayakumar S; Angayarkanni T; Pounammal P; Senthilganesh S; Kandeeban S
    Pharmazie; 2002 May; 57(5):306-7. PubMed ID: 12061252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and antitumor screening of new 1,7-diphenyl-3-(1,3-disubstituted-1H-pyrazole-4-carbonyl)-[1,2,4]triazolo[4,3-a]pyrimidin-5(1H)-ones.
    Shawali AS; Sherif SM; Darwish MA; El-merzabani MM
    Arch Pharm Res; 2010 Jan; 33(1):55-60. PubMed ID: 20191343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on condensed 1,4-dihydropyridine derivatives and their calcium modulatory activities.
    Aydin F; Safak C; Simşek R; Erol K; Ulgen M; Linden A
    Pharmazie; 2006 Aug; 61(8):655-9. PubMed ID: 16964703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of 2,3-dihydro-3-amino-6-phenyl-2-thioxothieno [2,3-d] pyrimidin-4 (1H)-one and of potential antiinflammatory agents 2-aryl-7-phenyl-3H, 9H-pyrimido [2,1-b]thieno-[2',3':4,5]]1,3,4] thiadiazin-9-ones.
    Santagati A; Modica M; Santagati M; Caruso A; Cutuli V
    Pharmazie; 1994 Jan; 49(1):64-5. PubMed ID: 8140133
    [No Abstract]   [Full Text] [Related]  

  • 35. Synthesis of cyclopentapyridine and thienopyridine derivatives as potential calcium channel modulators.
    Gündüz MG; Safak C; Kaygısız B; Koşar BC; Simşek R; Erol K; Linden A
    Arzneimittelforschung; 2012 Apr; 62(4):167-75. PubMed ID: 22286976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Convenient one pot synthesis of some novel derivatives of thiazolo[2,3-b]dihydropyrimidinone possessing 4-methylthiophenyl moiety and evaluation of their antibacterial and antifungal activities.
    Ashok M; Holla BS; Kumari NS
    Eur J Med Chem; 2007 Mar; 42(3):380-5. PubMed ID: 17070617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of some substituted quinazolinediones as potential inhibitors of smooth muscle contraction.
    Akgün H; Hollstein U; Hurwitz L
    J Pharm Sci; 1988 Sep; 77(9):735-9. PubMed ID: 3225765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, evaluation of the calcium antagonistic activity and biotransformation of hexahydroquinoline and furoquinoline derivatives.
    Simşek R; Safak C; Erol K; Ataman S; Ulgen M; Linden A
    Arzneimittelforschung; 2003; 53(3):159-66. PubMed ID: 12705170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and smooth muscle calcium channel antagonist effects of alkyl 1,4-dihydro-2,6-dimethyl-4-(pyridinyl)-5-[2-(4,5-dihydro- 4,4-dimethyloxazolin-2-yl)]-3-pyridinecarboxylates.
    Anana RD; Knaus EE
    Arch Pharm (Weinheim); 1996; 329(8-9):408-12. PubMed ID: 8915102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis and pharmacological screening of a series of N1-(substituted) aryl-5,7-dimethyl-2-(substituted)pyrido(2,3-d)-pyrimidin-4(3H)-ones as potential histamine H1-receptor antagonists.
    Suhagia BN; Chhabria MT; Makwana AG
    J Enzyme Inhib Med Chem; 2006 Dec; 21(6):681-91. PubMed ID: 17252940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.